[  1] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  2] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  3] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  4] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  5] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  6] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  7] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  8] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[  9] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 10] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 11] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 12] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 13] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 14] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 15] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 16] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 17] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 18] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 19] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 20] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 21] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 22] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 23] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 25] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 26] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 27] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 28] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 29] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 30] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 31] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 32] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 33] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 34] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 35] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 36] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 37] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 38] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 39] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 40] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 41] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 42] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 43] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 44] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 45] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 47] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 48] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 49] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 50] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 51] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 52] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 53] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 55] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 56] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 57] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 58] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 59] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 60] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 61] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 62] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 63] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 64] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 65] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 66] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 67] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 68] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 69] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 70] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 71] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 72] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 73] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 74] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 75] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 76] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 77] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 78] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 79] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[ 80] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[ 81] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 82] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 83] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 84] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 85] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 86] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 87] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 88] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[ 90] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 91] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 92] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[ 93] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[ 94] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 95] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 96] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 97] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[ 98] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[ 99] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[100] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[101] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[102] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[103] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[104] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[108] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[109] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[110] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[111] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[112] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[113] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[114] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[115] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[116] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[117] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[118] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[119] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[120] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[122] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[123] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[124] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[126] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[127] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[128] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[129] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[130] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[131] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[132] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[133] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[134] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[136] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[137] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[138] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[140] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[141] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[142] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[143] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[146] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[147] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[148] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[149] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[150] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[151] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[152] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[154] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[155] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[156] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[157] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[158] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[159] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[160] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[162] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[164] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[165] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[166] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[167] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[168] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[169] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[170] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[171] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[172] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[173] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[176] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[177] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[178] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[179] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[180] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[181] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[182] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[183] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[184] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[185] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[186] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[187] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[188] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[189] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[190] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[191] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[193] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[194] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[195] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[198] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[200] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[201] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[202] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[203] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[204] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[205] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[206] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[208] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[209] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[210] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[211] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[212] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[213] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[214] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[215] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[216] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[218] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[219] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[220] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[221] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[222] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[223] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[224] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[225] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[226] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[227] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[228] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[229] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[230] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[231] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[232] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[236] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[237] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[238] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[239] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[240] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[241] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[242] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[243] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[244] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[245] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[246] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[247] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[248] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[249] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[251] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[252] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[253] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[254] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[255] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[259] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[260] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[261] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[262] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[263] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[264] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[265] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[266] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[267] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[268] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[270] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[272] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[273] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[274] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[275] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[278] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[280] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[281] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[282] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[283] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[284] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[285] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[286] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[288] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[289] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[290] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[291] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[292] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[293] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[295] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[296] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[297] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[298] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[299] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[300] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[301] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[302] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[303] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[304] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[305] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[306] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[307] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[308] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[309] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[310] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[311] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[312] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[313] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[314] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[315] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[316] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[317] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[318] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[319] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[320] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[321] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[322] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[323] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[324] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[325] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[326] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[327] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[328] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[329] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[330] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[331] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[332] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[333] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[334] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[335] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[336] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[337] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[338] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[339] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[340] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[341] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[342] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[343] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[344] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[345] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[346] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[347] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[348] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[349] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[350] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[351] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[352] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[353] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[354] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[355] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[356] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[357] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[358] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[359] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[360] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[361] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[362] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[363] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[364] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[365] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[366] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[367] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[368] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[369] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[370] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[371] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[372] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[373] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[374] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[375] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[376] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[377] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[378] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[379] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[380] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[381] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[382] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[383] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[384] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[385] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[386] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[387] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[388] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[389] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[390] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[391] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[392] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[393] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[394] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[395] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[396] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[397] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[398] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[399] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[400] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[401] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[402] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[403] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[404] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[405] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[406] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[407] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[408] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[409] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[410] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[411] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[412] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[413] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[414] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[415] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[416] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[417] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[418] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[419] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[420] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[421] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[422] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[423] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[424] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[425] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[426] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[427] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[428] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[429] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[430] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[431] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[432] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[433] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[434] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[435] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[436] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[437] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[438] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[439] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[440] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[441] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[442] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[443] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[444] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[445] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[446] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[447] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[448] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[449] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[450] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[451] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[452] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[453] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[454] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[455] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[456] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[457] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[458] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[459] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[460] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[461] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[462] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[463] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[464] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[465] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[466] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[467] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[468] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[469] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[470] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[471] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[472] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[473] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[474] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[475] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[476] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[477] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[478] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[479] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[480] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[481] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[482] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[483] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[484] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[485] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[486] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[487] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[488] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[489] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[490] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[491] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[492] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[493] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[494] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[495] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[496] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[497] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[498] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[499] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[500] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[501] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[502] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[503] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[504] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[505] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[506] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[507] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[508] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[509] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[510] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[511] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[512] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[513] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[514] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[515] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[516] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[517] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[518] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[519] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[520] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[521] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[522] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[523] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[524] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[525] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[526] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[527] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[528] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[529] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[530] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[531] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[532] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[533] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[534] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[535] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[536] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[537] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[538] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[539] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[540] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[541] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[542] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[543] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[544] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[545] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[546] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[547] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[548] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[549] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[550] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[551] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[552] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[553] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[554] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[555] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[556] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[557] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[558] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[559] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[560] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[561] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[562] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[563] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[564] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[565] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[566] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[567] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[568] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[569] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[570] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[571] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[572] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[573] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[574] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[575] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[576] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[577] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[578] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[579] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[580] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[581] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[582] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[583] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[584] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[585] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[586] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[587] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[588] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[589] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[590] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[591] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[592] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[593] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[594] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[595] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[596] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[597] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[598] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[599] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[600] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[601] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[602] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[603] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[604] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[605] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[606] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[607] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[608] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[609] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[610] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[611] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[612] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[613] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[614] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[615] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[616] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[617] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[618] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[619] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[620] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[621] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[622] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[623] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[624] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[625] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[626] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[627] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[628] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[629] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[630] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[631] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[632] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[633] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[634] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[635] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[636] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[637] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[638] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[639] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[640] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[641] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[642] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[643] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[644] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[645] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[646] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[647] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[648] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[649] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[650] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[651] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[652] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[653] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[654] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[655] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[656] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[657] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[658] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[659] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[660] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[661] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[662] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[663] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[664] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[665] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[666] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[667] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[668] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[669] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[670] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[671] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[672] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[673] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[674] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[675] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[676] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[677] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[678] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[679] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[680] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[681] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[682] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[683] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[684] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[685] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[686] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[687] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[688] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[689] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[690] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[691] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[692] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[693] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[694] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[695] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[696] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[697] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[698] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[699] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[700] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[701] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[702] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[703] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[704] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[705] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[706] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[707] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[708] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[709] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[710] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[711] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[712] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[713] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[714] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[715] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[716] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[717] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[718] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[719] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[720] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[721] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[722] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[723] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[724] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[725] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[726] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[727] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[728] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[729] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[730] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[731] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[732] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[733] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[734] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[735] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[736] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[737] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[738] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[739] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[740] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[741] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[742] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[743] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[744] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[745] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[746] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[747] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[748] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[749] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[750] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[751] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[752] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[753] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[754] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[755] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[756] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[757] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[758] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[759] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[760] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[761] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[762] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[763] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[764] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[765] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[766] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[767] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[768] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[769] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[770] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[771] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[772] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[773] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[774] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[775] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[776] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[777] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[778] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[779] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[780] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[781] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[782] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[783] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[784] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[785] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[786] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[787] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[788] Analysts/Institutional Investor Meet/Con. Call Updates (2025-11-19)/Natural Capsules Limited has informed the Exchange about Transcript
[789] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[790] Press Release (2026-02-06)/Jubilant Pharmova Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Press Release alongwith Earnings Presentation on the financials and operational performance of the Company for the quarter and nine months ended December 31, 2025".
[791] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[792] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[793] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[794] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[795] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[796] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-17)/Hikal Limited has informed the Exchange about Transcript
[797] Press Release (2026-03-12)/Natural Capsules Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Natural Biogenex and Fermbox Bio Enter Strategic Framework andManufacturing Agreements to Strengthen Fermentation-Based CDMOCapabilities".
[798] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/Aarti Pharmalabs Limited has informed the Exchange about Transcript
[799] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[800] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[801] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-09)/Viyash Scientific Limited has informed the Exchange about Transcript
[802] Shareholders meeting (2026-03-27)/JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on April 28, 2026
[803] Press Release (2026-02-05)/Windlas Biotech Limited has informed the Exchange regarding a press release dated February 05, 2026, titled " Windlas Biotech Limited Reports its 9M & Q3FY26 Financial Results ".
[804] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[805] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-16)/GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Transcript
[806] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-14)/Divi's Laboratories Limited has informed the Exchange about Transcript
[807] Outcome of Board Meeting (2026-02-12)/Cohance Lifesciences Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[808] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-18)/IPCA Laboratories Limited has informed the Exchange about Transcript
[809] Outcome of Board Meeting (2026-02-05)/Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
[810] Investor Presentation (2026-02-20)/Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
[811] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[812] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[813] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026
[814] Analysts/Institutional Investor Meet/Con. Call Updates (2026-03-27)/Sanofi Consumer Healthcare India Limited has informed the Exchange about the transcript of the Institutional Investor Meet held on Tuesday, 24th March 2026